• Sophia Lin, Jacques Neelankavil, and Yibin Wang.
• Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD.
• J. Cardiothorac. Vasc. Anesth. 2021 Mar 1; 35 (3): 730-740.

AbstractCardiovascular diseases are the number one cause of mortality in the world, particularly among the aging population. Major adverse cardiac events are also a major contributor to perioperative complications, affecting 2.6% of noncardiac surgeries and up to 18% of cardiac surgeries. Cardioprotective effects of volatile anesthetics and certain intravenous anesthetics have been well-documented in preclinical studies; however, their clinical application has yielded conflicting results in terms of their efficacy. Therefore, better understanding of the underlying mechanisms and developing effective ways to translate these insights into clinical practice remain significant challenges and unmet needs in the area. Several recent reviews have focused on mechanistic dissection of anesthetic-mediated cardioprotection. The present review focuses on recent clinical trials investigating the cardioprotective effects of anesthetics in the past five years. In addition to highlighting the main outcomes of these trials, the authors provide their perspectives about the current gap in the field and potential directions for future investigations.Copyright © 2020 Elsevier Inc. All rights reserved.

9 keywords...

hide…